Albert David Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Albert David Limited with three other
companies in this sector in INDIA :
Amrutanjan Health Care Limited
(2020
sales of 2.61 billion Indian Rupees [US$35.74 million]
of which 92%
was OTC Products),
RPG Life Sciences Limited
(3.76 billion Indian Rupees [US$51.34 million]
), and
Kopran Limited
(3.59 billion Indian Rupees [US$49.14 million]
of which 51%
was Bulk Drugs).
Sales Analysis.
Albert David Limited reported sales of 3.20 billion Indian Rupees (US$43.73 million)
for the
fiscal
year ending
March of 2020.
This
represents
a very small
increase of 1.1%
versus 2019, when the company's sales were 3.16 billion Indian Rupees .
The sales level in 2020 was fairly close to the level five years ago: in 2015, Albert David Limited had sales
of 3.22 billion Indian Rupees .